Madison, WI – October 14, 2015 – Propeller Health today announced that it has been named by FierceMedicalDevices as one of 2015’s “Fierce 15” Med Tech companies.
According to FierceMedicalDevices, Fierce 15 celebrates the spirit of being “fierce” – championing innovation and creativity, even in the face of intense competition. This is FierceMedicalDevices’ fourth annual Fierce 15 selection. A complete list of “Fierce 15” companies and highlights for Propeller can be found online at http://www.fiercemedicaldevices.com/special-reports/2015-fierce-15.
David Van Sickle, Propeller’s CEO, stated “It is an honor to be selected as one of this year’s Top 15 companies by FierceMedicalDevices. We sincerely appreciate this recognition of our leadership in digital health and our efforts to move the field of respiratory health forward in ways that are meaningful to both patients and practitioners.”
Propeller is an FDA-cleared digital health platform designed to help patients and their physicians better understand asthma and COPD and help to improve outcomes. With proprietary sensor technology, software, and services, Propeller’s platform remotely monitors use of inhaled rescue and controller medications, analyzes patient trends, and provides regular feedback. The Propeller system has FDA-granted claims to increase adherence to therapy, predict oncoming exacerbations, and help reduce the frequency of symptoms and exacerbations in asthma and COPD.
FierceMedicalDevices is an internationally recognized daily report reaching a network of over 90,000 med tech industry professionals, providing subscribers with an authoritative analysis of the day’s top stories. Every year FierceMedicalDevices evaluates hundreds of private companies from around the world for its annual Fierce 15 list, which is based on a variety of factors such as the strength of its technology, partnerships, venture backers and a competitive market position.
Founded in 2010, Propeller is the leading provider of an FDA-cleared digital health platform that helps reduce the cost of care while delivering better quality of life for individuals with chronic respiratory disease. Backed by Safeguard Scientifics (NYSE: SFE), the Social+Capital Partnership, California HealthCare Foundation, Kapor Capital and other investors, Propeller has been used by patients with asthma or COPD in over 35 commercial programs across the US including major healthcare systems, payers, employers and other commercial partners. Company recognition includes TEDMED Innovation Showcase, White House Champion of Change, and Bluetooth Breakthrough Product awards. Visit http://propellerhealth.com/contact/ to request more information.
FierceMedicalDevices keeps biopharma executives, device developers, engineers, and researchers updated on the must-know news, trends and developments in medical devices and diagnostics. More than 90,000 top industry professionals rely on FierceMedicalDevices for an insider briefing on the day’s top stories. Signup is free www.fiercemedicaldevices.com/sign-up.
Follow us @ https://twitter.com/PropellerHealth